This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
How does rosemary improve memory and cognitive function?
Rosemary improves cognitive function primarily through its volatile compound 1,8-cineole, which inhibits acetylcholinesterase, the enzyme responsible for breaking down acetylcholine (Evidence Level B). By preserving acetylcholine levels, rosemary supports neurotransmission essential for learning and memory. Additionally, its antioxidant compounds, carnosic acid and rosmarinic acid, protect neurons from oxidative stress. Research suggests that even the aroma of rosemary essential oil can enhance cognitive performance, supporting its traditional reputation as a memory tonic.
Does rosemary interact with blood thinners or other medications?
Yes, rosemary can interact with anticoagulant and antiplatelet medications such as warfarin, aspirin, and clopidogrel (Evidence Level D). Rosemary impairs platelet aggregation, which may increase the risk of bleeding when combined with these drugs. It may also interact with diabetes medications by lowering blood sugar levels, potentially causing hypoglycemia. Additionally, rosemary affects cytochrome P450 liver enzymes, which could alter the metabolism of various prescription drugs. Patients taking these medications should consult a healthcare provider before use.
What is the recommended daily dosage for rosemary supplements?
The standard adult dosage for rosemary is 1-2 grams of dried herb prepared as a tea, taken three times daily (Evidence Level Traditional). For standardized extracts, a dose of 200-350 mg daily is commonly recommended. These dosages are based on traditional use and pharmacological studies rather than large-scale clinical trials. Users should start with lower doses to assess tolerance, as high doses can cause gastrointestinal irritation. Essential oil dosages differ significantly and should only be used under professional guidance due to toxicity risks.
Is rosemary safe to take during pregnancy and breastfeeding?
Rosemary is considered unsafe during pregnancy when taken in medicinal doses (Evidence Level D). High therapeutic amounts may stimulate uterine contractions or menstrual flow, potentially increasing the risk of miscarriage. While culinary amounts used for seasoning food are generally considered safe, pregnant women should avoid concentrated supplements and rosemary essential oil. Due to insufficient safety data, breastfeeding women are also advised to avoid medicinal doses. Always consult a qualified healthcare provider before using herbal supplements during pregnancy.
Can rosemary cause seizures or other serious side effects?
Yes, high doses of rosemary, particularly the essential oil, can induce seizures due to the presence of camphor, which is neurotoxic in large amounts (Evidence Level D). Individuals with seizure disorders or epilepsy should strictly avoid rosemary essential oil and high-dose supplements. Other potential side effects include gastrointestinal irritation, allergic reactions, and contact dermatitis. Large doses may also raise blood pressure, making it contraindicated for individuals with hypertension. Adverse effects are rare at normal culinary or recommended supplemental doses.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Rosemary (Salvia rosmarinus) is a medicinal plant native to the Mediterranean region used for therapeutic, culinary, and preservative purposes [PMID:30621719, 38284599]. It exhibits a wide range of pharmacological activities, including antioxidant, anti-inflammatory, and neuroprotective effects [PMID:30621719, 39096378].
Background
Rosemary (Rosmarinus officinalis L. or Salvia rosmarinus) is an evergreen bushy shrub belonging to the Lamiaceae family, primarily growing along the Mediterranean Sea and sub-Himalayan areas [PMID:32963731, 32455585].
Traditional uses
In folk medicine, it has been used as an antispasmodic, mild analgesic, circulatory tonic, and to treat intercostal neuralgia, headaches, migraine, insomnia, emotional upset, depression, and memory dysfunction [PMID:32963731, 32086980].
Active compounds
Bioactive constituents include phenolic compounds, alkaloids, saponins, tannins, flavonoids, and essential oils [PMID:39096378, 30181448]. Key active compounds include rosmarinic acid, carnosic acid, carnosol, and ursolic acid [PMID:40783038, 27869665, 32455585].
Mechanism of action
Rosemary acts through several mechanisms: inhibition of oxidative stress and inflammatory mediators (such as TNF-α, IL-6, and IL-17) [PMID:33044022]; inhibition of cholinesterase and modulation of dopaminergic and oxytocinergic systems [PMID:38258779]; and activation of KCNQ3/KCNQ5 voltage-gated potassium channels via carnosic acid [PMID:39153478]. Antitumor effects are linked to antiangiogenic properties, epigenetic actions, and increased expression of onco-suppressor genes [PMID:32532056].
Clinical evidence
Evidence BCognitive and Psychological Health (University Students)
Oral administration of 500 mg rosemary twice daily for one month significantly improved prospective and retrospective memory, reduced anxiety and depression, and improved sleep quality (excluding sleep latency and duration) [PMID:29389474]
Evidence BAlopecia
Rosemary oil is used to enhance circulation and extend the anagen phase to promote hair growth and scalp health [PMID:40656290]; standardized extracts have been tested for efficacy in testosterone-induced alopecia in rat models [PMID:40632089]
Evidence CNeurological Disorders
Shows potential in treating Alzheimer's disease, Parkinson's disease, migraine, and cognitive disorders through neuroprotective and anti-apoptotic effects [PMID:35873824, 40055645]
Evidence CMetabolic Syndrome
Active constituents like rosmarinic and carnosic acid are explored for managing obesity, insulin resistance, hypertension, and dyslipidemia [PMID:40783038]
Evidence CCancer
Preclinical evidence suggests anticancer potential, particularly in colorectal cancer, through the modulation of signaling pathways and apoptosis [PMID:21955093, 32532056]
Safety & adverse effects
Generally considered safe for consumption and topical use, but allergic reactions and contact dermatitis have been reported [PMID:39096378, 23827646]. High doses may cause atrophic and degenerative changes in the liver and kidney, increasing blood urea nitrogen (BUN) and aspartate aminotransferase (AST) while reducing total serum protein [PMID:39096378].
Dosage & administration
In one clinical trial, 500 mg was administered orally twice daily for one month [PMID:29389474]. No PubMed data available for general guidelines. Consult a healthcare provider.
Evidence summary
The evidence consists primarily of preclinical reviews and in vitro/in vivo studies (Level C/D), with limited randomized controlled trials (Level B) supporting benefits for memory, anxiety, and hair growth.
PubMed sources
1.PMID: 30621719 (2019) — Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. · Journal of biomedical science
2.PMID: 39096378 (2025) — Toxicity and safety of rosemary (Rosmarinus officinalis): a comprehensive review. · Naunyn-Schmiedeberg's archives of pharmacology
3.PMID: 32963731 (2020) — Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders. · Iranian journal of basic medical sciences
4.PMID: 29389474 (2018) — Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. · Complementary therapies in clinical practice
5.PMID: 40055645 (2025) — Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer's disease.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 40656290 (2025) — Rosmagain™ as a Natural Therapeutic for Hair Regrowth and Scalp Health: A Double-Blind, Randomized, Three-Armed, Placebo-Controlled Clinical Trial. · Cureus
7.PMID: 37241981 (2023) — Application of Rosmarinic Acid with Its Derivatives in the Treatment of Microbial Pathogens. · Molecules (Basel, Switzerland)
8.PMID: 40072366 (2025) — The Impact of Rosemary and Ginger Extracts on Aging and Healthspan in Drosophila. · Aging and disease
9.PMID: 32532056 (2020) — Anticancer Activity of Rosmarinus officinalis L.: Mechanisms of Action and Therapeutic Potentials. · Nutrients
10.PMID: 30181448 (2018) — Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review. · Medicines (Basel, Switzerland)
11.PMID: 40783038 (2025) — Exploring the therapeutic potential of rosemary in metabolic syndrome: From traditional use to modern research. · Fitoterapia
12.PMID: 35873824 (2022) — Neuroprotective Potential of Aromatic Herbs: Rosemary, Sage, and Lavender. · Frontiers in neuroscience
13.PMID: 30693502 (2019) — Hypolipidemic effects of Rosmarinus officinalis L. · Journal of cellular physiology
14.PMID: 39153478 (2024) — Molecular and circuit determinants in the globus pallidus mediating control of cocaine-induced behavioral plasticity. · Neuron
15.PMID: 27869665 (2016) — Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols. · Nutrients
16.PMID: 40632089 (2025) — Topical application of standardized capsicum and rosemary extracts promotes hair growth in testosterone induced alopecia in Wistar rats: Histological and morphometric evaluation. · Indian journal of pharmacology
17.PMID: 32455585 (2020) — Rosemary (Rosmarinus officinalis L., syn Salvia rosmarinus Spenn.) and Its Topical Applications: A Review. · Plants (Basel, Switzerland)
18.PMID: 32086980 (2020) — Investigation of rosemary herbal extracts (Rosmarinus officinalis) and their potential effects on immunity. · Phytotherapy research : PTR
19.PMID: 23827646 (2014) — Rosmarinus officinalis L. as cause of contact dermatitis. · Allergologia et immunopathologia
20.PMID: 36471846 (2022) — Phenotypic diversity of rosemary (Salvia rosmarinus Schleid.) accessions for qualitative characters. · Heliyon
21.PMID: 32454694 (2019) — Characterization of Gamma-Irradiated Rosmarinus officinalis L. (Rosemary). · Turkish journal of pharmaceutical sciences
22.PMID: 33044022 (2021) — An updated review of protective effects of rosemary and its active constituents against natural and chemical toxicities. · Phytotherapy research : PTR
23.PMID: 38284599 (2024) — Rosemary: Unrevealing an old aromatic crop as a new source of promising functional food additive-A review. · Comprehensive reviews in food science and food safety
24.PMID: 26170168 (2015) — Diterpenes from rosemary (Rosmarinus officinalis): Defining their potential for anti-cancer activity. · Cancer letters
25.PMID: 21955093 (2011) — Rosemary and cancer prevention: preclinical perspectives. · Critical reviews in food science and nutrition
26.PMID: 11041135 (2000) — Antimicrobial effect of rosemary extracts. · Journal of food protection
27.PMID: 38258779 (2024) — Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies. · Current drug targets
28.PMID: 34651071 (2021) — Rosemary (Salvia rosmarinus): Health-promoting benefits and food preservative properties. · International journal of nutrition
29.PMID: 17900043 (2007) — Potential of rosemary oil to be used in drug-resistant infections. · Alternative therapies in health and medicine